Kymmy Lorrain

A Selective Novel Peroxisome Proliferator-Activated Receptor (PPAR)-α Antagonist Induces Apoptosis and Inhibits Proliferation of CLL Cells In Vitro and In Vivo

D. Lorrain, Xiao-Jie Yan, N. Chiorazzi, 2015, Molecular medicine.

Identification and In Vivo Evaluation of Myelination Agent PIPE-3297, a Selective Kappa Opioid Receptor Agonist Devoid of β-Arrestin-2 Recruitment Efficacy.

D. Lorrain, K. Stebbins, A. Broadhead, 2024, ACS chemical neuroscience.

Discovery of a brain penetrant small molecule antagonist targeting LPA1 receptors to reduce neuroinflammation and promote remyelination in multiple sclerosis

D. Lorrain, K. Stebbins, A. Broadhead, 2024, Scientific reports.